SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-24-015591
Filing Date
2024-02-21
Accepted
2024-02-21 10:57:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea0200365-13dlichti_elevai.htm SC 13D 49497
  Complete submission text file 0001213900-24-015591.txt   51023
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Subject) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94408 | Film No.: 24656966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 650 GEORGIA ST #3200 VANCOUVER A1 V6B4P7
Business Address
Braeden Lichti (Filed by) CIK: 0001982476 (see all company filings)

Type: SC 13D